BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21204113)

  • 1. Impact assessment of metabolite instability in the development and validation of LC-MS/MS bioanalytical assays for measurement of rosuvastatin in human plasma and urine samples.
    Cui Y; Kowalski K; Van Parys M; Miller D; Hansen P; Liang X; Dean B; Chen L
    Biomed Chromatogr; 2024 Jan; 38(1):e5766. PubMed ID: 37920134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS Approaches for Oxysterols in Various Biosamples.
    Kømurcu KS; Wilson SR; Røberg-Larsen H
    Adv Exp Med Biol; 2024; 1440():57-71. PubMed ID: 38036875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.
    Ewles M; Goodwin L
    Bioanalysis; 2011 Jun; 3(12):1379-97. PubMed ID: 21679032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of Drugs, Drug Candidates, and Metabolites in Blood and Plasma.
    Reed GA
    Curr Protoc Pharmacol; 2016 Dec; 75():7.6.1-7.6.12. PubMed ID: 27960029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Triphenylmethyl Alkylation Pre-Column Derivatization Method for HPLC Quantitative Analysis of Chemically Unstable Halogenated Compounds.
    Lu J; Shi Y; Ye X; Yuan S; Yang X; Sun X; Wu T
    ACS Omega; 2024 Apr; 9(13):15311-15319. PubMed ID: 38585103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Sensitive and Specific LC-MS/MS Method for IWR-1-Endo, a Wnt Signaling Inhibitor: Application to a Cerebral Microdialysis Study.
    Nair S; Davis A; Campagne O; Schuetz JD; Stewart CF
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dried blood spots in clinical lipidomics: optimization and recent findings.
    Ferreira HB; Guerra IMS; Melo T; Rocha H; Moreira ASP; Paiva A; Domingues MR
    Anal Bioanal Chem; 2022 Oct; 414(24):7085-7101. PubMed ID: 35840669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis.
    Oh HS; Kim T; Gu DH; Lee TS; Kim TH; Shin S; Shin BS
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyte recovery in LC-MS/MS bioanalysis: An old issue revisited.
    Kumar D; Gautam N; Alnouti Y
    Anal Chim Acta; 2022 Mar; 1198():339512. PubMed ID: 35190119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma.
    Schwarz R; Seiler ERD; Sender S; Pews-Davtyan A; Murua Escobar H; Zechner D; Beller M; Junghanß C; Hinz B
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Sensitive, Specific and Reproducible UPLC-MS/MS Method for the Quantification of OJT007, A Novel Anti-Leishmanial Agent: Application to a Pharmacokinetic Study.
    Rincon Nigro M; Ma J; Awosemo OT; Xie H; Olaleye OA; Liang D
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations.
    Iacuzzi V; Posocco B; Zanchetta M; Gagno S; Poetto AS; Guardascione M; Toffoli G
    Pharm Res; 2021 May; 38(5):759-778. PubMed ID: 33846903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review.
    Harahap Y; Diptasaadya R; Purwanto DJ
    Drug Des Devel Ther; 2020; 14():5757-5771. PubMed ID: 33414636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-analytic evaluation of volumetric absorptive microsampling and integration in a mass spectrometry-based metabolomics workflow.
    Volani C; Caprioli G; Calderisi G; Sigurdsson BB; Rainer J; Gentilini I; Hicks AA; Pramstaller PP; Weiss G; Smarason SV; Paglia G
    Anal Bioanal Chem; 2017 Oct; 409(26):6263-6276. PubMed ID: 28815270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects.
    Ratnatilaka Na Bhuket P; El-Magboub A; Haworth IS; Rojsitthisak P
    Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):341-353. PubMed ID: 27683187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic approaches to optimizing peptide ADME properties.
    Di L
    AAPS J; 2015 Jan; 17(1):134-43. PubMed ID: 25366889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring by dried blood spot: progress to date and future directions.
    Wilhelm AJ; den Burger JC; Swart EL
    Clin Pharmacokinet; 2014 Nov; 53(11):961-73. PubMed ID: 25204403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silica coated paper substrate for paper-spray analysis of therapeutic drugs in dried blood spots.
    Zhang Z; Xu W; Manicke NE; Cooks RG; Ouyang Z
    Anal Chem; 2012 Jan; 84(2):931-8. PubMed ID: 22145627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices.
    Li W; Zhang J; Tse FL
    Biomed Chromatogr; 2011 Jan; 25(1-2):258-77. PubMed ID: 21204113
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.